Reactivation of minimal change disease after Pfizer vaccine against COVID-19

The application period for 2026-27 B/C/C volunteer leadership roles is open now through April 30 | LEARN MORE

By JOM Staff

10.03.22

This case follows a 54-year-old woman with a medical history of hypertension who experienced reactivation of minimal change disease (MCD) after receiving the Pfizer vaccine against COVID-19. She had her first episode of MCD 15 days after receiving the influenza vaccine in 2018. She remained in remission for over 3 years following treatment with steroids. She experienced foamy urine and leg edema after receiving the first dose of the Pfizer vaccine, but she did not consult medical professionals until she received the second dose.

Read the Article